-
Eli Lilly and Company et al v. Actavis Laboratories UT, Inc. DC
- 1:16-cv-01119
- E.D. Va.
- Judge: Anthony J. Trenga +1
- Filed: 09/02/2016
- Closed: 07/12/2017
- Latest Docket Entry: 07/12/2017
- PACER
- Docket updated daily
2
Plaintiffs
6
Defendants
1
Accused
Product
1
Patent-in-Suit
314
Days in
Litigation
-
Eli Lilly and Company et al v. Actavis Laboratories UT, Inc. DC
- 1:16-cv-01119
- E.D. Va.
- Judge: Anthony J. Trenga +1
- Filed: 09/02/2016
- Closed: 07/12/2017
- Latest Docket Entry: 07/12/2017
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Referred Judge
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim | Outcome |
---|---|
All challenged claims |
Enforceable and Valid
Entry 267 |
-
Infringement
Actavis Laboratories UT Incorporated
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
10 mg10 mg generic tadalafil tablet10 mg generic tadalafil tablets20 mg generic tadalafil tablet20 mg generic tadalafil tablets20 mg generic tadalafil tablets pursuant to ANDA No. 09014125 mg2.5 mg generic tadalafil tablet2.5 mg generic tadalafil tablets5 mg5 mg generic tadalafil tablet5 mg generic tadalafil tablets | US 6,943,166 B1 | All Asserted Claims |
Infringement
Entry 321Entry 446 Entry 323 |
Ajanta Pharma Limited
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
10 mg generic tadalafil tablets20 mg generic tadalafil tablets2.5 mg generic tadalafil tablets5 mg generic tadalafil tablets | US 6,943,166 B1 | All Asserted Claims |
Infringement
Entry 329
|
Ajanta Pharma USA Incorporated
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
10 mg generic tadalafil tablets20 mg generic tadalafil tablets2.5 mg generic tadalafil tablets5 mg generic tadalafil tablets | US 6,943,166 B1 | All Asserted Claims |
Infringement
Entry 329
|
Zydus Pharmaceuticals (USA) Inc.
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
10 mg20 mg generic tadalafil tablets pursuant to ANDA No. 20588525 mg5 mg | US 6,943,166 B1 | All Asserted Claims |
Infringement
Entry 454
|